Last reviewed · How we verify
TRL1068
At a glance
| Generic name | TRL1068 |
|---|---|
| Sponsor | Trellis Bioscience LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosthetic Joint Infection (PHASE2)
- Study to Evaluate Safety and Activity of TRL1068 in Prosthetic Joint Infections (PHASE1)
- Study to Evaluate Safety and Activity of TRL1068 in Chronic Rhinosinusitis (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TRL1068 CI brief — competitive landscape report
- TRL1068 updates RSS · CI watch RSS
- Trellis Bioscience LLC portfolio CI